- Previous Close
0.0000 - Open
0.0410 - Bid 0.0520 x --
- Ask 0.7750 x 40000
- Day's Range
0.0410 - 0.0410 - 52 Week Range
0.0160 - 0.6650 - Volume
6 - Avg. Volume
170 - Market Cap (intraday)
1.05M - Beta (5Y Monthly) -5.81
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0900 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
AiXin Life International, Inc. develops, manufactures, markets, and sells healthcare, nutritional products, and wellness supplements in the People's Republic of China. The company operates through four segments: Products, Pharmacies, Hotel, and Manufacture and Sales. It offers herbs, greens, and traditional Chinese remedies; and functional products, such as weight management tools, probiotics, foods, and drinks; and rhino king, colostrum powder derived from goat's milk, tong li ke, gammaoling granules, amoxicillin capsules, loratadine tablets, and fuyang granules. The company provides products purchased from third parties, as well as advertising and marketing services. It sells its products through its pharmacies, direct marketing, e-commerce, exhibition events, conferences, and person-to-person marketing, as well, as an omni-channel business. The company is based in Chengdu, China.
www.aixinjituan.com207
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: AIXN
View MorePerformance Overview: AIXN
Trailing total returns as of 4/8/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: AIXN
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: AIXN
View MoreValuation Measures
Market Cap
1.05M
Enterprise Value
2.50M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.27
Price/Book (mrq)
--
Enterprise Value/Revenue
0.64
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-60.11%
Return on Assets (ttm)
-32.73%
Return on Equity (ttm)
--
Revenue (ttm)
3.91M
Net Income Avi to Common (ttm)
-2.35M
Diluted EPS (ttm)
-0.0900
Balance Sheet and Cash Flow
Total Cash (mrq)
610.83k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
1.19M